October 22nd 2024
Under terms of the deal, Sanofi would sell a 50% controlling stake in Opella to CD&R, while remaining a significant shareholder.
Amneal Pharmaceuticals, Metsera Strike Deal to Co-Develop Medicines for Obesity, Metabolic Diseases
October 1st 2024Partnership is expected to leverage Amneal’s global manufacturing and product development experience and Metsera’s portfolio of ultra-long acting injectables and oral nutrient-stimulated hormone analogs.
2024 Pharm Exec Top 50 Companies
June 14th 2024Highlighted by notable company and product maneuvering at the top and the continued dramatic growth of therapeutic settings such as GLP-1s, Pharm Exec’s latest listing of the top global biopharma sales producers is proof-positive of an industry in transition.